EudraGMP Homepage      
 
 
MIA | GMP | API REG | WDA | GDP | Sites Help
Wed 28 Oct 2026 03:31:49 BST
GMP Compliance Menu 
Search
GMP Certificates
Non-Compliance Report


Print Preview
                  
Print Preview (Short version)
                  
Back To Search

 

Landesamt Fuer Soziales Jugend Und Gesundheit

CERTIFICATE NUMBER: DE_ST_01_GMP_2026_0031

CERTIFICATE OF GMP COMPLIANCE OF A MANUFACTURER(1) , (2)

Part 1

Issued following an inspection in accordance with
Art. 111(5) of Directive 2001/83/EC as amended

The competent authority of Germany confirms the following:

The manufacturer: 8688958 Canada Inc.

Site address: 37 Chemin De L'Aeroport, Mansonville, Qc, J0E 1X0, Canada

OMS Organisation Id. / OMS Location Id.: ORG-100055803 / LOC-100099703


Has been inspected in connection with marketing authorisation(s) listing manufacturers located outside of the European Economic Area in accordance with Art. 111(4) of Directive 2001/83/EC transposed in the following national legislation:Sect. 72a para 1 sent. 1 No. 2 in conjunction with sent. 3 No. 1 German Medicinal Product Act (import certificate).


From the knowledge gained during inspection of this manufacturer, the latest of which was conducted on  2026-02-05 , it is considered that it complies with:

  • The principles and guidelines of Good Manufacturing Practice laid down in Directive (EU) 2017/1572. (3)

  • This certificate reflects the status of the manufacturing site at the time of the inspection noted above and should not be relied upon to reflect the compliance status if more than three years have elapsed since the date of that inspection. However, this period of validity may be reduced or extended using regulatory risk management principles by an entry in the Restrictions or Clarifying remarks field. Updates to restrictions or clarifying remarks can be identified through the EudraGMDP website (https://eudragmdp.ema.europa.eu/). This certificate is valid only when presented with all pages and both Parts 1 and 2.

     The authenticity of this certificate may be verified in EudraGMDP. If it does not appear, please contact the issuing authority.

    __________________________________________________________________________________________________________________________
    (1) The certificate referred to in paragraph Art. 111(5) of Directive 2001/83/ECis also applicable to importers.
    (2) Guidance on the interpretation of this template can be found in the Interpretation of the Union format for GMP certificate.
    (3) These requirements fulfil the GMP recommendations of WHO.

    Part 2

    Human Medicinal Products

    1  MANUFACTURING OPERATIONS
    1.2  Non-sterile products
       1.2.1  Non-sterile products (processing operations for the following dosage forms)
               1.2.1.17  Other: medicinal Cannabis flowers that have not been treated with ionizing radiation for microbial reduction(en)
    1.4  Other products or manufacturing activity
       1.4.1  Manufacture of
               1.4.1.1  Herbal products
    1.5  Packaging
       1.5.1  Primary Packaging
               1.5.1.17  Other non-sterile medicinal products: medicinal Cannabis flowers that have not been treated with ionizing radiation for microbial reduction(en)
    1.6  Quality control testing
       1.6.3  Chemical/Physical

    Clarifying remarks (for public users):
    The company 8688958 Canada Inc. conducts its business under the name LOT420. Contrary to the information on page 1, inspection and certificate issuance are carried out without reference to registration, as the Cannabis flowers are imported as bulk drugs for the manufacturing of magistral or officinal medicines in German pharmacies. The GMP certificate only refers to validated strains cultivated at the company's own GACP facility (adress: see page 1). The checks according to point 1.6.3 are exclusively in-process controls. All further quality control tests are outsourced to Eurofins Experchem Laboratories Inc., 1111 Flint Road, North York, ON M3J 3C7.

     

     



     
     
     
         
     
     
     
     
    The EudraGMDP database is maintained and operated by the EMA. Access to the general public is granted in order to enhance availability of information related to the EMA mandate. The content of the database is provided by the National Competent Authorities (NCA) of the EEA. For this reason, the EMA accepts no responsibility or liability whatsoever (including but not limited to any direct or consequential loss or damage it might occur to you and/or any other third party) arising out of or in connection with the information on this database. Any questions about the content should be addressed to the relevant NCA. Please click here to get list of NCA's.

    For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI.

    Documents issued by UK authorities up to and including 31 December 2020 remain available for consultation in EudraGMDP. However, they are no longer included or updated from 1 January 2021, with the exception of the documents pertaining to sites located in Northern Ireland.

    [EMA © 2014. EudraGMDP 6.5.4.8 build 2026/01/16 09:45]